Literature DB >> 30919208

Capsule-Delivered Fecal Microbiota Transplant Is Safe and Well Tolerated in Patients with Ulcerative Colitis.

Elizabeth Adler1, Adam Tabaa1, Zain Kassam2, Martin Zydek3, Jonathan Terdiman3, Najwa El-Nachef4.   

Abstract

Entities:  

Year:  2019        PMID： 30919208     DOI： 10.1007/s10620-019-05596-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.

Authors:  Sudarshan Paramsothy; Michael A Kamm; Nadeem O Kaakoush; Alissa J Walsh; Johan van den Bogaerde; Douglas Samuel; Rupert W L Leong; Susan Connor; Watson Ng; Ramesh Paramsothy; Wei Xuan; Enmoore Lin; Hazel M Mitchell; Thomas J Borody
Journal:  Lancet       Date:  2017-02-15       Impact factor: 79.321

2.  Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

Authors:  Dina Kao; Brandi Roach; Marisela Silva; Paul Beck; Kevin Rioux; Gilaad G Kaplan; Hsiu-Ju Chang; Stephanie Coward; Karen J Goodman; Huiping Xu; Karen Madsen; Andrew Mason; Gane Ka-Shu Wong; Juan Jovel; Jordan Patterson; Thomas Louie
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

3.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience.

Authors:  Samantha M Chin; Jenny Sauk; Jasmine Mahabamunuge; Jess L Kaplan; Elizabeth L Hohmann; Hamed Khalili
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-03       Impact factor: 11.382

4.  Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.

Authors:  Vinita Jacob; Carl Crawford; Shirley Cohen-Mekelburg; Monica Viladomiu; Gregory G Putzel; Yecheskel Schneider; Fatiha Chabouni; Sarah OʼNeil; Brian Bosworth; Viola Woo; Nadim J Ajami; Joseph F Petrosino; Ylaine Gerardin; Zain Kassam; Mark Smith; Iliyan D Iliev; Gregory F Sonnenberg; David Artis; Ellen Scherl; Randy S Longman
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

5.  Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Monika Fischer; Dina Kao; Colleen Kelly; Aishwarya Kuchipudi; Syed-Mohammed Jafri; Mark Blumenkehl; Douglas Rex; Mark Mellow; Nirmal Kaur; Harry Sokol; Gwen Cook; Matthew J Hamilton; Emmalee Phelps; Brian Sipe; Huiping Xu; Jessica R Allegretti
Journal:  Inflamm Bowel Dis       Date:  2016-10       Impact factor: 5.325

6.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

Authors:  Paul Moayyedi; Michael G Surette; Peter T Kim; Josie Libertucci; Melanie Wolfe; Catherine Onischi; David Armstrong; John K Marshall; Zain Kassam; Walter Reinisch; Christine H Lee
Journal:  Gastroenterology       Date:  2015-04-07       Impact factor: 22.682

Review 7.  Clostridium difficile infection and inflammatory bowel disease.

Authors:  Camelia Cojocariu; Carol Stanciu; Oana Stoica; Ana Maria Singeap; Catalin Sfarti; Irina Girleanu; Anca Trifan
Journal:  Turk J Gastroenterol       Date:  2014-12       Impact factor: 1.852

Review 8.  Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.

Authors:  Neeraj Narula; Zain Kassam; Yuhong Yuan; Jean-Frederic Colombel; Cyriel Ponsioen; Walter Reinisch; Paul Moayyedi
Journal:  Inflamm Bowel Dis       Date:  2017-10       Impact factor: 5.325

9.  Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.

Authors:  James D Lewis; Shaokun Chuai; Lisa Nessel; Gary R Lichtenstein; Faten N Aberra; Jonas H Ellenberg
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

Review 10.  Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Authors:  Sudarshan Paramsothy; Ramesh Paramsothy; David T Rubin; Michael A Kamm; Nadeem O Kaakoush; Hazel M Mitchell; Natalia Castaño-Rodríguez
Journal:  J Crohns Colitis       Date:  2017-10-01       Impact factor: 9.071
  10 in total
  4 in total

1.  Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis.

Authors:  Luciane de Fátima Caldeira; Helena H Borba; Fernanda S Tonin; Astrid Wiens; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

2.  Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy.

Authors:  Frederik Cold; Simon Mark Dahl Baunwall; Jens Frederik Dahlerup; Andreas Munk Petersen; Christian Lodberg Hvas; Lars Hestbjerg Hansen
Journal:  Therap Adv Gastroenterol       Date:  2021-08-31       Impact factor: 4.409

3.  Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis.

Authors:  Byron J Smith; Yvette Piceno; Martin Zydek; Bing Zhang; Lara Aboud Syriani; Jonathan P Terdiman; Zain Kassam; Averil Ma; Susan V Lynch; Katherine S Pollard; Najwa El-Nachef
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

4.  An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis.

Authors:  Taobi Huang; Jinlan Xu; Maoying Wang; Ke Pu; Longquan Li; Huiyun Zhang; Yuan Liang; Weiming Sun; Yuping Wang
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.